ADSB-FUB-187

ADSB-FUB-187 is a synthetic cannabinoid that is used in scientific research. It is part of the cannabinoid family, which includes both natural and synthetic substances. ADSB-FUB-187 is known for its potent agonistic behavior towards the CB1 and CB2 receptors, which are part of the endocannabinoid system in the human body.

Chemistry

ADSB-FUB-187 is a synthetic cannabinoid, meaning it is not naturally occurring but is instead created in a laboratory setting. It is structurally related to other synthetic cannabinoids such as FUB-APINACA and AB-FUBINACA. The exact chemical structure and synthesis process of ADSB-FUB-187 is proprietary information, typically held by the research institutions or companies that produce it.

Pharmacology

As a synthetic cannabinoid, ADSB-FUB-187 acts as an agonist at the CB1 and CB2 receptors. These receptors are part of the endocannabinoid system, which plays a role in a variety of physiological processes including pain sensation, mood, and memory. The exact pharmacological profile of ADSB-FUB-187 is still under investigation, but it is known to be a potent agonist, meaning it activates these receptors to a significant degree.

Research Use

ADSB-FUB-187 is primarily used in scientific research. It is often used in studies investigating the pharmacology of synthetic cannabinoids and their effects on the endocannabinoid system. Due to its potent agonistic activity, it can be used to study the effects of strong activation of the CB1 and CB2 receptors.

Legal Status

The legal status of ADSB-FUB-187 varies by country and region. In many places, it is considered a controlled substance due to its structural similarity to other synthetic cannabinoids, which are often subject to regulation. However, as a research chemical, it may be legally obtained and used under certain circumstances, such as for scientific research.

See Also

• Synthetic cannabinoids
• Endocannabinoid system
• CB1 receptor
• CB2 receptor